Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1923 1
1949 1
1960 1
1963 1
1964 1
1965 2
1967 1
1970 1
1971 1
1972 1
1973 1
1974 1
1976 2
1977 1
1978 3
1979 3
1980 1
1981 1
1982 4
1983 8
1984 1
1985 3
1986 5
1987 6
1988 13
1989 12
1990 17
1991 17
1992 21
1993 12
1994 17
1995 22
1996 22
1997 37
1998 37
1999 50
2000 55
2001 58
2002 63
2003 69
2004 97
2005 148
2006 144
2007 158
2008 191
2009 215
2010 311
2011 402
2012 346
2013 458
2014 456
2015 496
2016 478
2017 528
2018 604
2019 638
2020 805
2021 905
2022 596
Text availability
Article attribute
Article type
Publication date

Search Results

7,686 results
Results by year
Filters applied: . Clear all
Page 1
Targeting HNRNPU to overcome cisplatin resistance in bladder cancer.
Shi ZD, Hao L, Han XX, Wu ZX, Pang K, Dong Y, Qin JX, Wang GY, Zhang XM, Xia T, Liang Q, Zhao Y, Li R, Zhang SQ, Zhang JH, Chen JG, Wang GC, Chen ZS, Han CH. Shi ZD, et al. Among authors: han ch. Mol Cancer. 2022 Feb 7;21(1):37. doi: 10.1186/s12943-022-01517-9. Mol Cancer. 2022. PMID: 35130920 Free PMC article.
Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study.
Sandborn WJ, D'Haens GR, Reinisch W, Panés J, Chan D, Gonzalez S, Weisel K, Germinaro M, Frustaci ME, Yang Z, Adedokun OJ, Han C, Panaccione R, Hisamatsu T, Danese S, Rubin DT, Sands BE, Afzali A, Andrews JM, Feagan BG; GALAXI-1 Investigators. Sandborn WJ, et al. Among authors: han c. Gastroenterology. 2022 May;162(6):1650-1664.e8. doi: 10.1053/j.gastro.2022.01.047. Epub 2022 Feb 5. Gastroenterology. 2022. PMID: 35134323 Free article. Clinical Trial.
7,686 results